White Paper
To Aggregate or Not to Aggregate. (It's not really a question)

As all pharmaceutical manufacturers inch toward the DSCSA or FMD deadlines of full serialization, some are still questionning the need for aggregation. Will it simplify the process or will it create even more data? But really, aggregating to multiple levels of a parent-child relationships will streamline your process and give greater security. Read more...